Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

Diabetes
A FestaInsulin Resistance Atherosclerosis Study

Abstract

Elevated serum levels of acute-phase proteins, indicating chronic subclinical inflammation, have been associated with cardiovascular disease as well as the insulin resistance syndrome. Chronic inflammation may also be a risk factor for developing type 2 diabetes. We studied the concentrations of C-reactive protein (CRP), fibrinogen, and plasminogen activator inhibitor-1 (PAI-1) in 1,047 nondiabetic subjects in relation to incident diabetes within 5 years in the Insulin Resistance Atherosclerosis Study. Subjects with diabetes at follow-up (n = 144) had higher baseline levels of fibrinogen (mean +/- SD; 287.8 +/- 58.8 vs. 275.1 +/- 56.0 mg/dl; P = 0.013) as well as of CRP (median [interquartile range]; 2.40 [1.29, 5.87] vs. 1.67 mg/l [0.75, 3.41]; P = 0.0001) and PAI-1 (24 [15, 37.5] vs. 16 ng/ml [9, 27]; P = 0.0001) than nonconverters. The odds ratio (OR) of converting to diabetes was significantly increased with increasing baseline concentrations of the inflammatory markers. In contrast to PAI-1, the association of CRP and fibrinogen with incident diabetes was significantly attenuated after adjustment for body fat (BMI or waist circumference) or insulin sensitivity (S(I)), as assessed by a frequently sampled intravenous glucose...Continue Reading

References

Jan 1, 1985·Endocrine Reviews·R N BergmanM Ader
May 1, 1995·The Journal of Clinical Investigation·G S HotamisligilB M Spiegelman
Aug 1, 1993·Metabolism: Clinical and Experimental·B J Potter van LoonA E Meinders
Jan 1, 1993·Perspectives in Biology and Medicine·I Kushner
Feb 1, 1993·Arteriosclerosis and Thrombosis : a Journal of Vascular Biology·A R FolsomK K Wu
Oct 30, 1998·Diabetologia·J C Pickup, M A Crook
Jan 14, 1999·The New England Journal of Medicine·R Ross
Feb 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·M CesariG P Rossi
Mar 12, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·P A SakkinenR P Tracy
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·F SamadD J Loskutoff
Jan 20, 2000·The New England Journal of Medicine·UNKNOWN Heart Outcomes Prevention Evaluation Study InvestigatorsG Dagenais

❮ Previous
Next ❯

Citations

Jul 10, 2008·JAMA : the Journal of the American Medical Association·Joachim H IxUNKNOWN Health ABC Study
Jun 23, 2009·Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]·Katalin EderAndras K Fulop
May 3, 2005·Diabetologia·H Kolb, T Mandrup-Poulsen
Dec 8, 2006·Diabetologia·K S KrabbeB K Pedersen
Mar 29, 2007·Human Genetics·Christina L Wassel FyrUNKNOWN Health, Aging, Body Composition Study
Jun 16, 2010·Biogerontology·Andrea CorsonelloFabrizia Lattanzio
Sep 21, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·Angela W CoronaJonathan P Godbout
Mar 20, 2003·Current Diabetes Reports·Milagros G Huerta, Jerry L Nadler
Mar 20, 2003·Current Diabetes Reports·Daniel KramerJorge Plutzky
May 24, 2003·Current Diabetes Reports·Pierre Theuma, Vivian A Fonseca
Feb 7, 2004·Current Diabetes Reports·Robert S Lindsay, Barbara V Howard
Feb 7, 2004·Current Diabetes Reports·Emre Seli, Antoni J Duleba
Nov 23, 2006·Current Diabetes Reports·Carmen Mora, Juan F Navarro
Sep 4, 2007·Current Neurology and Neuroscience Reports·Rachel A Whitmer
Aug 7, 2012·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Soghra JarvandiMario Schootman
Jan 2, 2013·Indian Journal of Clinical Biochemistry : IJCB·Satinder KaurGaurav Singla
Nov 19, 2003·Biochemical and Biophysical Research Communications·David L CrandallRobert E Swillo
Mar 23, 2005·Current Opinion in Pharmacology·Bart De TaeyeDouglas E Vaughan
Sep 6, 2003·The American Journal of Cardiology·Steven M Haffner
Jul 26, 2003·Diabetes Research and Clinical Practice·Steven M Haffner
Jan 23, 2010·The British Journal of Nutrition·Angela D LieseRalph B D'Agostino
Mar 19, 2008·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J J M BouwmanR J A Diepersloot
Feb 25, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·A BelzaA Astrup
Nov 3, 2005·Nature Clinical Practice. Cardiovascular Medicine·Subodh VermaPaul M Ridker
Aug 20, 2008·Nature Clinical Practice. Cardiovascular Medicine·Kiran MusunuruSamia Mora
Feb 3, 2005·Nature Medicine·Melek C ArkanMichael Karin
Jul 13, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C HoldstockF A Karlsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

Biomarkers for Diabetes

This feed focuses on the latest research on biomarkers used for monitoring disease progression in diabetes.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.